Sugiyama Akiko, Matsuzaki Hiroshi, Motomura Chikako, Hiramoto Tetsuya, Nakahara Takeshi
Department of Allergology, National Hospital Organization Fukuoka National Hospital, Fukuoka, JPN.
Department of Pediatrics, National Hospital Organization Fukuoka National Hospital, Fukuoka, JPN.
Cureus. 2025 Jul 29;17(7):e88988. doi: 10.7759/cureus.88988. eCollection 2025 Jul.
Itching is a subjective symptom that is especially difficult to assess in pediatric atopic dermatitis (AD) patients with chronic pruritus since early infancy. This study aimed to assess the utility of the Itch Tracker (Maruho Co. Ltd., Osaka, Japan), a smartwatch application, in visualizing nocturnal scratching and facilitating shared decision-making (SDM) in two pediatric AD cases treated with nemolizumab. Objective monitoring revealed discrepancies between self-reported itch and actual scratching behavior, leading to appropriate treatment initiation and significant improvements in scratching behavior, Eczema Area and Severity Index (EASI), and numerical rating scale (NRS) scores. These results highlight the clinical value of behavioral visualization in enhancing SDM and optimizing management in pediatric AD.
瘙痒是一种主观症状,对于自婴儿早期就患有慢性瘙痒的小儿特应性皮炎(AD)患者而言,尤其难以评估。本研究旨在评估一款智能手表应用程序Itch Tracker(日本大阪丸红株式会社)在可视化夜间搔抓行为以及促进两名接受奈莫利珠单抗治疗的小儿AD病例的共同决策(SDM)方面的效用。客观监测揭示了自我报告的瘙痒与实际搔抓行为之间的差异,从而促成了适当的治疗启动,并使搔抓行为、湿疹面积和严重程度指数(EASI)以及数字评定量表(NRS)评分得到显著改善。这些结果凸显了行为可视化在增强小儿AD的共同决策和优化管理方面的临床价值。